Wedbush Reiterates Outperform on Damora Therapeutics, Maintains $35 Price Target
Damora Therapeutics Inc DMRA
$20.78
▼ -2.72%
($-0.58)
Open
$21.41
Prev Close
$21.36
Day Range
$20.49 – $21.89
52W Range
$16.50 – $29.22
Market Cap
$1.28B
Beta
-4.32
EPS (TTM)
$-141.43
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-10-29 |
| Shares Out. | 61,550,000 |
| Website | galecto.com/ ↗ |
| Phone | 13026587581 |
Damora Therapeutics Inc is a publicly traded company under the ticker symbol DMRA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-06-01)